BridgeBio Reports Q3 Revenue of $353.2 Million, Operating Loss of $11.6 Million

BridgeBio reported $253.2 million in U.S. Attruby revenue and said a one-time $75.0 million Bayer milestone aided its $11.6 million operating loss. Cash and securities totaled $1.5 billion as of Sept. 30, 2026.